Page last updated: 2024-08-23

pravastatin and Venous Thromboembolism

pravastatin has been researched along with Venous Thromboembolism in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blankenberg, S; Elliott, J; Espinoza, D; Glasziou, PP; Hague, W; Keech, AC; Nestel, PJ; Robledo, KP; Simes, J; Stewart, RA; Sullivan, DR; Tonkin, AM; White, HD; Zeller, T	1

Other Studies

1 other study(ies) available for pravastatin and Venous Thromboembolism

Article	Year
D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID Study. Circulation, 2018, 08-14, Volume: 138, Issue:7 Topics: Adult; Aged; Biomarkers; Coronary Disease; Female; Fibrin Fibrinogen Degradation Products; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Neoplasms; Pravastatin; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Up-Regulation; Venous Thromboembolism	2018

Article

Year

D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID Study.

Circulation, 2018, 08-14, Volume: 138, Issue:7

Topics: Adult; Aged; Biomarkers; Coronary Disease; Female; Fibrin Fibrinogen Degradation Products; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Neoplasms; Pravastatin; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Up-Regulation; Venous Thromboembolism

2018